These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 578850)

  • 1. Reversal of central anticholinergic syndrome by galanthamine.
    Baraka A; Harik S
    JAMA; 1977 Nov; 238(21):2293-4. PubMed ID: 578850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine).
    Cozanitis DA
    Anaesthesist; 1977 Dec; 26(12):649-50. PubMed ID: 603022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of central anticholinergic syndrome in man by physostigmine.
    Duvoisin RC; Katz R
    JAMA; 1968 Nov; 206(9):1963-5. PubMed ID: 5755090
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of the cholinesterase inhibitor galanthamine hydrobromide on normal sleep.
    Riemann D; Gann H; Dressing H; Müller WE; Aldenhoff JB
    Psychiatry Res; 1994 Mar; 51(3):253-67. PubMed ID: 8208872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angel's Trumpet psychosis: a central nervous system anticholinergic syndrome.
    Hall RC; Popkin MK; Mchenry LE
    Am J Psychiatry; 1977 Mar; 134(3):312-4. PubMed ID: 842711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of scopolamine on spontaneous yawning in men.
    Skorzewska A; Tesfaye Y; Krishnan B; Schwartz G; Thavundayil J; Lal S
    Neuropsychobiology; 1993; 27(1):17-20. PubMed ID: 8515822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of scopolamine (0.25-0.75 mg i.m.) on the quantitative EEG and the neuropsychological status of healthy volunteers.
    Sannita WG; Maggi L; Rosadini G
    Neuropsychobiology; 1987; 17(4):199-205. PubMed ID: 3441275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical EEG oscillations and network connectivity as efficacy indices for assessing drugs with cognition enhancing potential.
    Ahnaou A; Huysmans H; Jacobs T; Drinkenburg WH
    Neuropharmacology; 2014 Nov; 86():362-77. PubMed ID: 25181033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transdermal scopolamine as an anesthetic premedication].
    Murakawa T; Baba S; Satoh Y; Matsuki A; Oyama T
    Masui; 1987 May; 36(5):784-8. PubMed ID: 3656648
    [No Abstract]   [Full Text] [Related]  

  • 10. Delirium due to scopolamine patch in a 4-year-old boy.
    Lin YG; Chen PH; Chang FY; Wu LT; Liao KY; Wu TC
    J Formos Med Assoc; 2011 Mar; 110(3):208-11. PubMed ID: 21497284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine attenuates waking and sleep electroencephalographic markers of sleep homeostasis in humans.
    Landolt HP; Rétey JV; Tönz K; Gottselig JM; Khatami R; Buckelmüller I; Achermann P
    Neuropsychopharmacology; 2004 Oct; 29(10):1933-9. PubMed ID: 15257305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroencephalographic and blood chemistry responses to galanthamine hydrobromide in epileptic volunteers.
    Cozanitis D; Toivakka E; Dessypris A
    Anaesthesist; 1973 Jan; 22(1):31-3. PubMed ID: 4632556
    [No Abstract]   [Full Text] [Related]  

  • 13. Galanthamine hydrobromide versus neostigmine. A plasma cortisol study in man.
    Cozanitis DA
    Anaesthesia; 1974 Mar; 29(2):163-8. PubMed ID: 4819071
    [No Abstract]   [Full Text] [Related]  

  • 14. Biperiden-induced delirium model in rats: a behavioral and electroencephalographic study.
    Tamura Y; Chiba S; Takasaki H; Tabata K; Ishimaru Y; Ishimoto T
    Brain Res; 2006 Oct; 1115(1):194-9. PubMed ID: 16938281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delirium from transdermal scopolamine in an elderly woman.
    Rozzini R; Inzoli M; Trabucchï M
    JAMA; 1988 Jul 22-29; 260(4):478. PubMed ID: 3385907
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticholinergic delirium in a case of Munchausen syndrome.
    Hollender MH; Jamieson RC; McKee EA; Roback HB
    Am J Psychiatry; 1978 Nov; 135(11):1407-9. PubMed ID: 707647
    [No Abstract]   [Full Text] [Related]  

  • 17. Galantamine attenuates the heroin seeking behaviors induced by cues after prolonged withdrawal in rats.
    Liu H; Lai M; Zhou X; Zhu H; Liu Y; Sun A; Ma B; Zhang F; Zhou W
    Neuropharmacology; 2012 Jun; 62(8):2515-21. PubMed ID: 22342742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EEG spectral power and sleepiness during 24 h of sustained wakefulness in patients with obstructive sleep apnea syndrome.
    Grenèche J; Krieger J; Erhardt C; Bonnefond A; Eschenlauer A; Muzet A; Tassi P
    Clin Neurophysiol; 2008 Feb; 119(2):418-28. PubMed ID: 18077207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delirium induced by poisoning with anticholinergic agents.
    Brizer DA; Manning DW
    Am J Psychiatry; 1982 Oct; 139(10):1343-4. PubMed ID: 7124991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible central anticholinergic syndrome following transdermal scopolamine in an ambulatory surgery patient.
    Norton JA; Khabiri B; Arbona FL; Kover AJ
    Can J Anaesth; 2011 Dec; 58(12):1149-50. PubMed ID: 21989550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.